ACUTE ISCHEMIC STROKE (AIS)
Clinical trials for ACUTE ISCHEMIC STROKE (AIS) explained in plain language.
Never miss a new study
Get alerted when new ACUTE ISCHEMIC STROKE (AIS) trials appear
Sign up with your email to follow new studies for ACUTE ISCHEMIC STROKE (AIS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could this drug shield the brain during a stroke?
Disease control CompletedThis study tested a drug called SCP776 in 120 people having a stroke caused by a blocked artery. All participants were already scheduled for a procedure to remove the clot. The goal was to see if the drug is safe and helps protect the brain from further damage. Half received the …
Matched conditions: ACUTE ISCHEMIC STROKE (AIS)
Phase: PHASE2 • Sponsor: Silver Creek Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 05:56 UTC
-
New stroke drug shows promise in early safety trial
Disease control CompletedThis study tested a drug called MCI-186 in 36 adults who had a recent ischemic stroke (a clot blocking blood flow to the brain). The main goal was to check if the drug is safe and how the body processes it. Participants received the drug or a placebo within 1 to 24 hours after th…
Matched conditions: ACUTE ISCHEMIC STROKE (AIS)
Phase: PHASE2 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Balloon catheters tested for better stroke recovery
Knowledge-focused CompletedThis study looked at whether using a balloon-guided catheter is better than a standard one for treating acute ischemic stroke. About 110 adults with stroke in the front part of the brain took part. Researchers measured how well blood flow was restored and checked patients' qualit…
Matched conditions: ACUTE ISCHEMIC STROKE (AIS)
Phase: NA • Sponsor: University Hospital Heidelberg • Aim: Knowledge-focused
Last updated May 17, 2026 05:54 UTC